Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures

Neonatal Pharmacodynamic and Pharmacokinetic Characteristics and Implications for Pharmacotherapeutic Decisions

by John Brock Harris, Pharm.D., BCPS, BCPPS
  • Duration: 60 Mins
  • Credits: 1 CERP, 1 R-CERP
  • Learning Format: Webinar
  • Handout: No
  • Origin: Neonatal 2017
Abstract:

This presentation will focus on the pharmacodynamic and pharmacokinetic principles in neonatal populations and the implications for medication selection and monitoring. We will discuss parameters related to these principles and how pharmacotherapeutic regimens are determined using them. Absorption, distribution, metabolism, and elimination of medications and the clinical impact of neonatal patient characteristics and medication properties on pharmacotherapeutic decisions will also be presented. We will also contrast medications and why medications may be preferred for some neonatal disease states due to medication characteristics. The information provided will act as a foundation for pharmacotherapeutic recommendations based on patient and mediation specific properties for neonatal disease states.

Learning Objectives:

Objective 1: Determine the impact of pharmacodynamic and pharmacokinetic principles in medication selection for selected disease states
Objective 2: Contrast medication dosing strategies based on neonatal pharmacodynamics and pharmacokinetic parameters
Objective 3: Develop a process for monitoring pharmacotherapeutic regimens based on normal and changing pharmacodynamic and pharmacokinetic patient characteristics

Categories: Neonates
Presentations: 6  |  Hours / CE Credits: 6  |  Viewing Time: 4 Weeks